Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Follow-Up Questions
What is Medtronic PLC (MDT)'s P/E Ratio?
The P/E ratio of Medtronic PLC is 26.403
Who is the CEO of Medtronic PLC?
Mr. Geoffrey Martha is the Executive Chairman of the Board of Medtronic PLC, joining the firm since 2011.
What is the price performance of MDT stock?
The current price of MDT is $89.69, it has decreased 1.11% in the last trading day.
What are the primary business themes or industries for Medtronic PLC?
Medtronic PLC belongs to Health Care industry and the sector is Health Care
What is Medtronic PLC market cap?
Medtronic PLC's current market cap is $115.0B
Is Medtronic PLC a buy, sell, or hold?
According to wall street analysts, 30 analysts have made analyst ratings for Medtronic PLC, including 7 strong buy, 13 buy, 18 hold, 1 sell, and 7 strong sell
